Salary
Location
Mexico, Mexico City
Location
Mexico City
Remote Working
Hybrid: Office/Remote
Job Categories
Drug Safety
Job Type
Permanent
Description
We are currently seeking a Pharmacovigilance Reporting Associate/Senior Associate(Leader role) to join our diverse and dynamic team!-Location: Mexico City (office-based an average of 3 days per week)
Reference
JR129080
Expiry date
01/01/0001
Read more
Shortlist Save this role
Salary
Location
Mexico, Mexico City
Location
Mexico City
Remote Working
Office Based
Job Categories
Drug Safety
Job Type
Permanent
Description
We are currently seeking a Senior Pharmacovigilance Reporting Associate to join our diverse and dynamic team. As a Senior Pharmacovigilance Reporting Associate at ICON, you will be essential in ensuri
Reference
JR129330
Expiry date
01/01/0001
Read more
Shortlist Save this role
Salary
Location
Mexico, Mexico City
Location
Mexico City
Remote Working
Hybrid: Office/Remote
Job Categories
Drug Safety
Job Type
Permanent
Description
We are currently seeking a Senior Pharmacovigilance Systems Associate to join our diverse and dynamic team. As a Senior Pharmacovigilance Systems Associate at ICON, you will be pivotal in managing and
Reference
JR128071
Expiry date
01/01/0001
Read more
Shortlist Save this role
.png)
Teaser label
IndustryContent type
BlogsPublish date
05/22/2025
Summary
World Schizophrenia Awareness Day 2025 Every year on 24 May, World Schizophrenia Awareness Day offers a vital opportunity to raise awareness, dismantle stigma, and celebrate the strength of individ
.png)
Teaser label
Inside ICONContent type
BlogsPublish date
05/08/2025
Summary
Standing Strong on Ovarian Cancer Day: ICON's Commitment to Advancing Care Ovarian cancer remains one of the most challenging gynaecologic malignancies, both in terms of detection and treatmen
.png)
Teaser label
IndustryContent type
BlogsPublish date
05/07/2025
Summary
Patient Centricity in Clinical Research: What it is and Why it Matters In the past, clinical research was designed around the needs of sponsors, researchers, and regulatory bodies. Patients were of